CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY – Get Free Report) was the recipient of a large drop in short interest during the month of June. As of June 30th, there was short interest totaling 207 shares, a drop of 62.5% from the June 15th total of 552 shares. Based on an average daily volume of 4,625 shares, the days-to-cover ratio is currently 0.0 days.
CSPC Pharmaceutical Group Stock Down 3.3%
OTCMKTS CSPCY opened at C$4.04 on Wednesday. The firm’s 50-day moving average is C$3.78 and its two-hundred day moving average is C$4.41. CSPC Pharmaceutical Group has a 12 month low of C$3.26 and a 12 month high of C$5.83.
About CSPC Pharmaceutical Group
CSPC Pharmaceutical Group Limited is a China-based pharmaceutical company headquartered in Shijiazhuang, Hebei Province. Established in 1979, the group has grown through organic expansion and strategic acquisitions to become one of the country’s leading manufacturers of active pharmaceutical ingredients (APIs), generic formulations and innovative drug candidates. CSPC is publicly traded in Hong Kong (HKEX: 1093) and maintains American Depositary Receipts on the OTC market (OTCMKTS: CSPCY), reflecting its dual focus on domestic market leadership and international visibility.
The company operates through three primary business segments: bulk pharmaceuticals, finished dosage forms and research-driven products.
Further Reading
- Five stocks we like better than CSPC Pharmaceutical Group
- As the Iran War Resumes, 2 Energy ETFs Ride Oil’s Renewed Rally
- Tower Semiconductor’s AI Rally Is Built on a Light-Speed Bet
- Marriott vs. Viking: Why the Better Quarter Doesn’t Mean the Better Decade
- Why Fastenal’s Latest Drop Could Be Its Biggest Opportunity Yet
Receive News & Ratings for CSPC Pharmaceutical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSPC Pharmaceutical Group and related companies with MarketBeat.com's FREE daily email newsletter.
